Bionovo Inc., of Emeryville, Calif., said it entered a $5 million securities purchase agreement with Socius CG II Ltd., a Bermuda-based subsidiary of Socius Capital Group LLC. Under the terms, the company has the right, at its discretion, to sell to Socius up to a total of $5 million of redeemable Series A preferred stock, payable in tranches, over a two-year period.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter